Intro Flashcards

(46 cards)

1
Q

Angiotensin Receptor blocker suffix

A

-sartan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Calcium channel blocker suffix

A

-pine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Beta blocker suffix

A

-olol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dose definition

A

Amount of drug administered in a given formulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In a dose-response curve, the response is ______ to the number of ______ ________ by the drug and it is not always _______

A

proportional, receptors occupied, linear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In a dose-response curve, response is affected by _________ and __________

A

Affinity and receptor signal transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In a dose-response curve, the curve represents the __________ over which the drug is ___________ and the _____ _____ or the response that can be expected

A

Dosage, effective, peak effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Threshold dose

A

Where response begins & increases in magnitude until a response plateau is reached

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ceiling effect

A

The point at which there is no further response (even if dosage increases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Potency & high potency

A
  • threshold dose that produces a given response

- higher potency means less dose required for response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Efficacy

A

Dose ranges over which drug has desired effect

-response increases as dosage increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

First pass effect

Definition and what route experiences this?

A
  • metabolism/destruction of drug in liver before reaching site of action
  • enteral (oral) meds experience, paraenteral meds don’t (bypass GI)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bioavailability

Definition

A

% of drug administered that reaches bloodstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bioavailability

Depends on:

A
  1. Route of administration
  2. Drugs ability to cross membrane barriers
  3. Extent of first pass mechanism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Volume of distribution

Definition

A

Amount of drug administered/ concentration of drug in plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

If Vd= total amount of body H20

A

Uniform body distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

If Vd> total body H20

A

Drug is being concentrated in tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

If Vd

A

Drug is being retained in bloodstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Distribution

Definition

A

Moving the drug throughout the body

20
Q

Volume of distribution depends on:

A
  1. Tissue permeability
  2. Blood flow
  3. Plasma protein binding
  4. Sub cellular protein binding
21
Q

Vd and tissue permeability

A

Highly lipid soluble molecules cross membrane more easily

22
Q

Vd and blood flow

A

Bloodstream carries drugs to highly perfused organs

23
Q

Negative venule pressure pulls drug from ____ back to _____.

Positive arteriole pressure draws drugs from ____ to _____

A

Tissues, blood

Blood, tissues

24
Q

Vd and plasma protein binding

A
Inactive= drug is bound to plasma protein and can't leave blood
Active= drug is free and can go to tissues
25
Subcellular protein binding
Drug gets trapped w/in cell (usually lysosome)
26
Metabolism of drug occurs in
Primarily liver | Lungs, kidneys, GI, skin
27
Factors affecting metabolism
1. Tissue/organ damage 2. Metabolic inhibitors 3. Enzyme induction
28
Competitive inhibition
Inhibition of the enzyme that metabolizes drug B by drug A, decreases metabolism of drug B
29
Induction of metabolism
Induction of the enzyme that metabolizes drug B by drug A, increases metabolism of drug B by increasing enzyme quantity
30
Elimination/Biotransformation
Chemical altering of a drug to metabolize via enzymes to deactivate the drug
31
Oxidation
Usual method of elimination, phase 1 reaction | -via endoplasmic smooth reticulum via enzymes (O2, H)
32
Reduction
Phase 1 reaction of elimination | In cell cytoplasm via enzymes (O2, H)
33
Hydrolysis
Original compound is broken into parts via enzymes, phase 1 elimination
34
Conjugation
Phase 2 elimination reaction | -phase 1 metabolite joins another compound for excretion via enzymes on ER and in cytoplasm
35
Excretion | Definition & occurs at
Eliminating active form of drug, units of mL/min suggest drug is being removed from specific volume of blood occurs at kidneys
36
Factors affecting excretion
Reabsorption, polarity (polar, ionized drug excreted and non-polar drugs reabsorbed), blood flow to organ, extraction ratio, concentration
37
Clearance | Definition & dependent on:
Ability of organs to clear a drug | Dependent on: organ ability to extract drug from plasma and perfusion
38
Half life
Amount of time required for 50% of drug remaining in body to be eliminated
39
Half life dependent on
Clearance and volume of distribution
40
Oral administration
Enteral, easiest for self administration, safe/controlled entry to system -drug must have high lipid solubility, undergoes first pass effect Ex: oral, sublingual, rectal
41
Oral administration disadvantages
Limited or erratic absorption of some drugs
42
Transdermal administration
Bypasses GI and first pass effect, more direct, more predictable quantity Ex: injection, IV, sub-q, IM, TD, topical, inhaled
43
Transdermal disadvantages
Drug must be able to pass through intact dermal layers
44
Continuous administration
Matching the rate of administration w/ the rate of elimination once the desired plasma concentration is achieved
45
Interval administration
Dosage is adjusted to provide an average plasma concentration over the dosing period -interval will affect size of dosage needed to maintain same relative plasma concentration
46
ACE Inhibitor suffix
-pril